导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -30.31% | 1044/1050 |
| 近一周 | -5.31% | 1081/1104 |
| 近一月 | -12.54% | 1089/1102 |
| 近一季 | -20.04% | 977/1092 |
| 近半年 | -37.36% | 1068/1070 |
| 近一年 | -30.52% | 991/1018 |
| 近两年 | 26.59% | 711/926 |
| 近三年 | -23.86% | 786/834 |
| 成立以来 | 187.33% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.47% 594/1070 |
-15.96% 1035/1101 |
- - |
- - |
| 2025 | 34.33% 409/1065 |
3.74% 497/1014 |
-0.23% 710/1038 |
35.94% 265/1050 |
-4.53% 692/1065 |
| 2024 | -14.92% 855/1011 |
-17.31% 934/960 |
-9.52% 848/983 |
18.95% 88/991 |
-4.41% 626/1011 |
| 2023 | -19.59% 662/952 |
6.73% 231/880 |
-8.56% 713/895 |
-14.58% 763/915 |
-3.54% 377/952 |
| 2022 | -32.94% 678/867 |
-23.16% 674/773 |
7.50% 373/806 |
-19.39% 739/845 |
0.71% 410/867 |
| 2021 | 42.22% 32/740 |
-3.04% 270/580 |
25.26% 84/659 |
6.10% 107/704 |
10.36% 78/740 |
| 2020 | 127.52% 7/554 |
-8.29% 362/419 |
50.91% 4/466 |
11.75% 211/517 |
47.11% 6/554 |
| 2019 | 73.12% 25/410 |
29.32% 412/1146 |
-7.77% 900/1228 |
19.81% 16/390 |
21.15% 13/410 |
| 2018 | -27.52% 185/349 |
- - |
-12.07% 599/990 |
0.91% 147/1000 |
-12.77% 701/1080 |
| 2017 | 7.06% 148/285 |
- - |
- - |
- - |
- - |
| 2016 | -6.44% 51/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇丰晋信智造先锋股票C VS. 东吴新产业精选股票A(580008) |